- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02828475
CALYPSO Pilot Study: Machine Learning Based Predictions of Surgical Complications (CALYPSO)
July 2, 2018 updated by: Duke University
Pilot Study for a Clinical Analytical Platform for Surgical Outcomes
This is a pilot study of surgical patients whose postoperative care will be augmented with a personalized risk prediction platform (CALYPSO app).
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
CALYPSO is a software platform that uses machine learning techniques to create personalized risk predictions for postoperative complications.
Individual risk factors are then linked to best-practice interventions tailored to the individual patient.
The investigator aims to test the hypothesis that using CALYPSO-augmented postoperative care will reduce complication rates in patients undergoing elective general surgery.
Subjects undergoing surgery will be assigned to the CALYPSO intervention in the postoperative period.
Study Type
Observational
Enrollment (Actual)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients undergoing high risk general and oncologic abdominal surgery.
Description
Inclusion Criteria:
- >18 years of age
- Undergoing elective surgery
- Undergoing high risk colon, rectal, pancreas, gastric surgery with predicted length of stay greater or equal to 3 days
Exclusion Criteria:
- Surgeries with less than 3 days of anticipated length of stay (e.g. stoma takedown)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
CALYPSO-augmented
Patients' postoperative care will be augmented with the CALYPSO platform.
|
Software platform of machine-learning based predictive models of surgical complication.
Previous standard of care based on surgeon judgement alone.
|
|
Historical Control
Patients' postoperative care was performed using standard practice, before adopting the CALYPSO platform
|
Previous standard of care based on surgeon judgement alone.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Thirty Day Overall Complications
Time Frame: 30 days after surgery
|
30 days after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Thirty Day Mortality
Time Frame: 30 days after surgery
|
30 days after surgery
|
|
|
Wound Complications
Time Frame: 30 days after surgery
|
Includes superficial, deep, organ space infections, and wound dehiscence
|
30 days after surgery
|
|
Cardiac Complications
Time Frame: 30 days after surgery
|
includes myocardial infarction, cardiac arrest
|
30 days after surgery
|
|
Respiratory Complications
Time Frame: 30 days after surgery
|
includes unplanned reintubation, pneumonia, failure to wean from ventilator >48 hours after surgery
|
30 days after surgery
|
|
Thrombotic complications
Time Frame: 30 days after surgery
|
includes deep vein thrombosis, pulmonary emobolism
|
30 days after surgery
|
|
Renal Complications
Time Frame: 30 days after surgery
|
includes acute renal failure, renal failure requiring dialysis
|
30 days after surgery
|
|
urinary tract infections
Time Frame: 30 days after surgery
|
30 days after surgery
|
|
|
Neurologic complications
Time Frame: 30 days after surgery
|
includes stroke, peripheral nerve injury, coma
|
30 days after surgery
|
|
Septic complications
Time Frame: 30 days after surgery
|
includes sepsis and septic shock
|
30 days after surgery
|
|
Unplanned reoperation
Time Frame: 30 days after surgery
|
30 days after surgery
|
|
|
unplanned readmission
Time Frame: 30 days after surgery
|
30 days after surgery
|
|
|
bleeding complications
Time Frame: up to 72 hours after surgery
|
needing at least 1 unit of pRBC
|
up to 72 hours after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Zhifei Sun, MD, Duke University Department of Surgery
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2016
Primary Completion (Actual)
January 1, 2017
Study Completion (Actual)
February 1, 2017
Study Registration Dates
First Submitted
July 7, 2016
First Submitted That Met QC Criteria
July 8, 2016
First Posted (Estimate)
July 11, 2016
Study Record Updates
Last Update Posted (Actual)
July 3, 2018
Last Update Submitted That Met QC Criteria
July 2, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- Pro00072563
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Infection
-
PolyPid Ltd.CompletedPostoperative Wound Infection Superficial Incisional | Postoperative Wound Infection Deep Incisional Surgical SiteIsrael
-
Military Medical AcademyRecruitingPostoperative Wound Infection Superficial Incisional | Postoperative Wound Infection Deep Incisional Surgical SiteBulgaria
-
Cairo UniversityRecruitingPostoperative Infection | Cesarean Section Complications | Vaginal InfectionEgypt
-
Charite University, Berlin, GermanyUnknownPostoperative Wound Infection | Postoperative OutcomeGermany
-
Carilion ClinicSmith & Nephew, Inc.; DeRoyal Industries, Inc.CompletedImpaired Wound Healing | Postoperative Wound Infection-deepUnited States
-
Mashhad University of Medical SciencesUnknown
-
Pulmatrix Inc.TerminatedPost Operative Wound Infection | Postoperative Wound Infection-deepUnited States
-
Baylor College of MedicineMedical College of Wisconsin; US Department of Veterans Affairs; Michael E. DeBakey...CompletedPostoperative Wound InfectionUnited States
-
Sahlgrenska University Hospital, SwedenCompleted
-
University of ZurichCompletedProsthetic Joint Infection | Surgical Site Infection | Prosthesis and Implants | Postoperative Wound Infection Deep Incisional Surgical SiteSwitzerland
Clinical Trials on CALYPSO
-
MoximedWithdrawnOsteoarthritis, Knee
-
Varian, a Siemens Healthineers CompanyCompleted
-
Memorial Sloan Kettering Cancer CenterVarian Medical SystemsCompletedNon-small Cell Lung Cancer (NSCLC)United States
-
Institut du Cancer de Montpellier - Val d'AurelleActive, not recruiting
-
PfizerCompletedRheumatoid ArthritisBelgium, United States, Hungary, Croatia, Japan, Romania, Colombia, Netherlands, Germany, Mexico, Russian Federation
-
Institut PasteurCentre Pasteur du Cameroun; Cameroon Society of Epidemiology (CaSE); Centre International... and other collaboratorsCompleted
-
Meshalkin Research Institute of Pathology of CirculationCompletedCoronary Artery Disease | Ischemic Heart Disease | Coronary Atherosclerosis | Coronary Artery StenosisRussian Federation
-
RaelCitruslabsCompletedDysmenorrhea | Menstrual CrampsUnited States